Investors Recent News Oct 15, 2020 Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting Sep 24, 2020 Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer Sep 21, 2020 Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer View All Upcoming Events There are no upcoming events at this time. View All Past Events Sep 16, 2020 at 3:00 PM EDT H.C. Wainwright 22nd Annual Global Investment Conference Apr 23, 2020 at 8:30 AM EDT DKN-01 Gynecologic Cancers Program Update Call & Webcast Mar 4, 2020 at 8:40 AM EST Cowen 40th Annual Health Care Conference View All
Sep 24, 2020 Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
Sep 21, 2020 Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer
